Based on our previous study and data, we confirmed that both PHF5A and DOCK5 variants promoted HNSCC progression and that PHF5A could enhance the expression of DOCK5 variants in HNSCC. This evidence concerns the gene DOCK5 and head and neck squamous cell carcinoma.